+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genfit - logo

GENFIT is a biopharmaceutical company that focuses on developing diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. Its lead pipeline product elafibranor (GFT505) has recently completed a positive Phase 2b study in NASH (Non-Alcoholic Steato-Hepatitis). Genfit SA was founded in 1999 and is headquartered in Loos, France.

From
Cardiometabolic Disease Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Cardiometabolic Disease Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • December 2018
  • 54 Pages
From
From
PPAR-Beta / Delta Agonist - Pipeline Insight, 2022 - Product Thumbnail Image

PPAR-Beta / Delta Agonist - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 60 Pages
From
From
Biliary Cirrhosis Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Biliary Cirrhosis Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • November 2018
  • 142 Pages
From
From
From
Loading Indicator